NEO - NeoGenomics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
3.37B
Enterprise Value 3
3.33B
Trailing P/E
1,468.18
Forward P/E 1
87.30
PEG Ratio (5 yr expected) 1
5.89
Price/Sales (ttm)
8.91
Price/Book (mrq)
6.77
Enterprise Value/Revenue 3
8.81
Enterprise Value/EBITDA 6
67.81

Trading Information

Stock Price History

Beta (5Y Monthly) 1.05
52-Week Change 399.82%
S&P500 52-Week Change 325.78%
52 Week High 333.55
52 Week Low 316.04
50-Day Moving Average 329.53
200-Day Moving Average 324.53

Share Statistics

Avg Vol (3 month) 3752.1k
Avg Vol (10 day) 3749.92k
Shares Outstanding 5104.41M
Float 100.65M
% Held by Insiders 16.08%
% Held by Institutions 189.13%
Shares Short (Dec 30, 2019) 46.92M
Short Ratio (Dec 30, 2019) 48.95
Short % of Float (Dec 30, 2019) 49.06%
Short % of Shares Outstanding (Dec 30, 2019) 46.63%
Shares Short (prior month Nov 28, 2019) 46.04M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:100
Last Split Date 3Apr 15, 2003

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 0.55%
Operating Margin (ttm)5.41%

Management Effectiveness

Return on Assets (ttm)2.19%
Return on Equity (ttm)0.51%

Income Statement

Revenue (ttm)378.44M
Revenue Per Share (ttm)4.01
Quarterly Revenue Growth (yoy)51.50%
Gross Profit (ttm)127.27M
EBITDA 49.14M
Net Income Avi to Common (ttm)2.06M
Diluted EPS (ttm)0.02
Quarterly Earnings Growth (yoy)5.90%

Balance Sheet

Total Cash (mrq)178.89M
Total Cash Per Share (mrq)1.71
Total Debt (mrq)138.71M
Total Debt/Equity (mrq)27.91
Current Ratio (mrq)4.24
Book Value Per Share (mrq)4.77

Cash Flow Statement

Operating Cash Flow (ttm)35.46M
Levered Free Cash Flow (ttm)14.24M